| Inventor | Institute |
|---|---|
| Abdo Alnabulsi | Vertebrate Antibodies Limited |
| SKU: | 158068 |
|---|---|
| Product description: | Tilapia lake virus (TiLV) is an enveloped, negative-sense, single-stranded RNA virus. TiLV appears to cause disease mainly in tilapia and tilapia hybrids (Oreochromis spp., Tilapia spp.), but has also been detected causing disease in other wild cichlids (Sarotherodon galilaeus, Tristramella spp.). This virus is found to be transmitted through direct horizontal transmission by cohabitation or transfer of live aquatic animals. Clinical signs of virus include behavioral changes, skin damage such as erosion, discolouration, skin hemorrhages and loss of scales, eyeball protrusion (exophthalmia) and abdominal swelling. There are currently no treatment or vaccines for TiLV. As the spread of TiLV has global impact in both commercial and ecological settings, anti-TLV can be a useful tool for virus detecting and further application such as disease prevention, treatment monitor and vaccine development. The antibody is a valuable research tool TiLV diagnostics, epidemiological monitoring and vaccine development. |
| Conjugation: | Unconjugated |
| Molecular weight: | 38 |
| Immunogen: | Ovalbumin-conjugated synthetic peptide. |
| Cat. #: | 158068 |
|---|---|
| Unit size: | 100 ug |
| Research Fields: | Cell biology; Immunology |
| Application: | ELISA |
| Target: | Tilapia Lake Virus |
| Reactivity: | Virus |
| Host: | Rabbit |
| Class: | Polyclonal |
| Target background: | Tilapia lake virus (TiLV) is an enveloped, negative-sense, single-stranded RNA virus. TiLV appears to cause disease mainly in tilapia and tilapia hybrids (Oreochromis spp., Tilapia spp.), but has also been detected causing disease in other wild cichlids (Sarotherodon galilaeus, Tristramella spp.). This virus is found to be transmitted through direct horizontal transmission by cohabitation or transfer of live aquatic animals. Clinical signs of virus include behavioral changes, skin damage such as erosion, discolouration, skin hemorrhages and loss of scales, eyeball protrusion (exophthalmia) and abdominal swelling. There are currently no treatment or vaccines for TiLV. As the spread of TiLV has global impact in both commercial and ecological settings, anti-TLV can be a useful tool for virus detecting and further application such as disease prevention, treatment monitor and vaccine development. The antibody is a valuable research tool TiLV diagnostics, epidemiological monitoring and vaccine development. |
|---|
| Format: | Liquid |
|---|---|
| Storage buffer: | Unpurified anti-serum from rabbit preserved in 0.02% Thiomersal |
| Shipping conditions: | Dry ice |
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151015 | Anti-CyclinA [E70.1] |
Key Info
Anti-CyclinA [E70.1]
|
View Tool | |||||||||||||||||||
| 151021 | Anti-CyclinB1 [V152] |
Key Info
Anti-CyclinB1 [V152]
|
View Tool | |||||||||||||||||||
| 151027 | Anti-HSVICP8 [10A3] |
Key Info
Anti-HSVICP8 [10A3]
|
View Tool | |||||||||||||||||||
| 151036 | Anti-ICAM1 [15.2] |
Key Info
Anti-ICAM1 [15.2]
|
View Tool | |||||||||||||||||||
| 151039 | Anti-Integrin aVb3 [23C6] |
Key Info
Anti-Integrin aVb3 [23C6]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.